Klein O, Polack G W, Surti T, Kegler-Ebo D, Smith S O, DiMaio D
Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
J Virol. 1998 Nov;72(11):8921-32. doi: 10.1128/JVI.72.11.8921-8932.1998.
The bovine papillomavirus E5 protein is a small, homodimeric transmembrane protein that forms a stable complex with the cellular platelet-derived growth factor (PDGF) beta receptor through transmembrane and juxtamembrane interactions, resulting in receptor activation and cell transformation. Glutamine 17 in the transmembrane domain of the 44-amino-acid E5 protein is critical for complex formation and receptor activation, and we previously proposed that glutamine 17 forms a hydrogen bond with threonine 513 of the PDGF beta receptor. We have constructed and analyzed mutant E5 proteins containing all possible amino acids at position 17 and examined the ability of these proteins to transform C127 fibroblasts, which express endogenous PDGF beta receptor. Although several position 17 mutants were able to transform cells, mutants containing amino acids with side groups that were unable to participate in hydrogen bonding interactions did not form a stable complex with the PDGF beta receptor or transform cells, in agreement with the proposed interaction between position 17 of the E5 protein and threonine 513 of the receptor. The nature of the residue at position 17 also affected the ability of the E5 proteins to dimerize. Overall, there was an excellent correlation between the ability of the various E5 mutant proteins to bind the PDGF beta receptor, lead to receptor tyrosine phosphorylation, and transform cells. Similar results were obtained in Ba/F3 hematopoietic cells expressing exogenous PDGF beta receptor. In addition, treatment of E5-transformed cells with a specific inhibitor of the PDGF receptor tyrosine kinase reversed the transformed phenotype. These results confirm the central importance of the PDGF beta receptor in mediating E5 transformation and highlight the critical role of the residue at position 17 of the E5 protein in the productive interaction with the PDGF beta receptor. On the basis of molecular modeling analysis and the known chemical properties of the amino acids, we suggest a structural basis for the role of the residue at position 17 in E5 dimerization and in complex formation between the E5 protein and the PDGF beta receptor.
牛乳头瘤病毒E5蛋白是一种小的同二聚体跨膜蛋白,它通过跨膜和近膜相互作用与细胞血小板衍生生长因子(PDGF)β受体形成稳定复合物,导致受体激活和细胞转化。44个氨基酸的E5蛋白跨膜结构域中的谷氨酰胺17对于复合物形成和受体激活至关重要,我们之前提出谷氨酰胺17与PDGFβ受体的苏氨酸513形成氢键。我们构建并分析了在第17位含有所有可能氨基酸的突变E5蛋白,并检测了这些蛋白转化表达内源性PDGFβ受体的C127成纤维细胞的能力。尽管几个第17位突变体能够转化细胞,但含有不能参与氢键相互作用的侧链基团氨基酸的突变体不能与PDGFβ受体形成稳定复合物或转化细胞,这与E5蛋白第17位与受体苏氨酸513之间的推测相互作用一致。第17位残基的性质也影响E5蛋白二聚化的能力。总体而言,各种E5突变蛋白结合PDGFβ受体、导致受体酪氨酸磷酸化和转化细胞的能力之间存在极好的相关性。在表达外源性PDGFβ受体的Ba/F3造血细胞中也获得了类似结果。此外,用PDGF受体酪氨酸激酶的特异性抑制剂处理E5转化细胞可逆转转化表型。这些结果证实了PDGFβ受体在介导E5转化中的核心重要性,并突出了E5蛋白第17位残基在与PDGFβ受体有效相互作用中的关键作用。基于分子建模分析和氨基酸的已知化学性质,我们提出了E5二聚化以及E5蛋白与PDGFβ受体之间复合物形成中第17位残基作用的结构基础。